Kobayashi Pharmaceutical Co., Ltd.

Factors to consider:

• Earnings expected soon, date: 2026-02-10 bmo
• Company pays dividends (annually): last record date 2025-12-31, amount 0.38$ (Y1.12%)
• Earnings for 9 months up through Q3 are close to our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

• 2024-12-31 to 2025-12-31 estimated range: [27.75$, 40.90$]
• 2025-12-31 to 2026-12-31 estimated range: [28.07$, 41.53$]

Financial Metrics affecting the KBYPF estimates:

• Positive: with PPE of 42.4 at the end of fiscal year the price was neutral
• Positive: 7.61 < Operating profit margin, % of 15.01
• Negative: Shareholder equity ratio, % of 80.44 > 64.37
• Negative: Inventory ratio change, % of 18.45 > 0.79
• Positive: 0.14 < Industry earnings per price (median), % of 0.38
• Negative: Industry operating profit margin (median), % of 1.21 <= 2.99
• Negative: Operating cash flow per share per price, % of 2.58 <= 6.66
• Positive: -4.43 < Investing cash flow per share per price, % of -4.23
• Positive: Industry inventory ratio change (median), % of -1.22 <= -0.18
• Positive: 1.84 < Return on assets ratio (scaled to [-100,100]) of 3.65
• Negative: Industry operating cash flow per share per price (median), % of 4.36 <= 5.48